News Releases
Nov 30 2005
Peregrine Pharmaceuticals Names Leading Influenza Expert to Its Scientific Resource Board
Nov 23 2005
Peregrine Pharmaceuticals Announces $6.7 Million Equity Financing
Nov 22 2005
Peregrine's Manufacturing Subsidiary Announces Bioproduction Contract With Major Leading Cancer Center
Nov 16 2005
Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board
Nov 3 2005
Peregrine Pharmaceuticals Announces Defense Department Grant to Study Tarvacin(TM) Platform for Prostate Cancer
Nov 2 2005
Peregrine Pharmaceuticals to Present at Rodman & Renshaw Annual Healthcare Conference
Oct 24 2005
Peregrine Pharmaceuticals Evaluating Therapeutic Opportunities for Tarvacin(TM) Against Influenza Viruses Including Avian Flu
Oct 21 2005
Peregrine Pharmaceuticals Announces Additional Tarvacin(TM) Clinical Trial Site at M.D. Anderson Cancer Center
Oct 20 2005
Peregrine Pharmaceuticals' Avid Bioservices Awarded Contract to Produce Clinical Phase Antibody
Oct 20 2005
Peregrine Pharmaceuticals to Webcast Annual Meeting of Stockholders